HR 1650 · 109th Congress 2005โ€“2007, ended

Stem Cell Research Investment Act of 2005

Latest action · Apr 14, 2005 Referred to the House Committee on Ways and Means.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 14, 2005
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Stem Cell Research Investment Act of 2005 - Amends the Internal Revenue Code to allow a tax credit for investment in qualified stem cell research bonds. Defines "qualified stem cell research bond" as any bond issued by a State or local government, 95 percent of the proceeds of which are to be used for interdisciplinary scientific and medical research relating to stem cells, therapy development relating to stem cells, and development of pharmacologies and treatments through clinical trials relating to stem cells. Imposes certain limitations on the use of stem cells that are supported by a bond issuance under this Act.

Sets a national limitation in 2006 through 2008 of $10 billion on the issuance of stem cell research bonds. Terminates the authority to issue such bonds after FY 2008.

Cosponsors 8

Members who signed on, in the order they did. Signatures ran from Apr 14, 2005 to Apr 27, 2005; 7 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-CTChristopher ShaysOriginalApr 14, 2005
D-VIDonna M. ChristensenOriginalApr 14, 2005
R-MNJim RamstadOriginalApr 14, 2005
D-IALeonard L. BoswellOriginalApr 14, 2005
D-CALoretta SanchezOriginalApr 14, 2005
R-DEMichael N. CastleOriginalApr 14, 2005
R-CTRob SimmonsOriginalApr 14, 2005
R-FLMark FoleyApr 27, 2005

Withdrew 1 Barbara Lee D-CA May 12, 2005

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseWays and Means Committee
Referred Apr 14, 2005

Actions 2

Everything that happened, newest first.

  1. Apr 14, 2005Introduced in House
  2. Apr 14, 2005Referred to the House Committee on Ways and Means.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Internal Revenue Code of 1986 to allow tax credits to holders of stem cell research bonds.
Short Titles as Introduced
Stem Cell Research Investment Act of 2005

Subjects

Assigned by the Library of Congress. Policy area: Taxation.

Text 1

Each version as it was printed, newest first.

  1. Apr 14, 2005Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.